We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

56 hedge funds and large institutions have $645M invested in BeOne Medicines Ltd in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 11

44% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 9

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

28% more capital invested

Capital invested by funds: $504M → $645M (+$140M)

4% more funds holding

Funds holding: 54 → 56 (+2)

0.1% more ownership

Funds ownership: 3.3% → 3.4% (+0.1%)

Holders
56
Holders Change
+2
Holders Change %
+3.7%
% of All Funds
1.39%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
13
Increased
20
Reduced
11
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MAM
Myriad Asset Management
Hong Kong
+$12M
2
BlackRock
BlackRock
New York
+$9.49M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$6.26M
4
ACM
Ariose Capital Management
Hong Kong
+$5.83M
5
CS
Candriam SCA
Luxembourg
+$4.19M

Top Sellers

1
FI
Fosun International
China
-$3.81M
2
Millennium Management
Millennium Management
New York
-$3.14M
3
PRCM
Pine River Capital Management
Minnesota
-$1.87M
4
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
-$1.52M
5
DCM
DAFNA Capital Management
California
-$1.41M
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
51
Tower Research Capital (TRC)
New York
$88K +$87.7K +2,407 New
UBS Group
52
UBS Group
Switzerland
$73K +$72.7K +1,995 New
US Bancorp
53
US Bancorp
Minnesota
$43K +$1.24K +34 +3%
Citigroup
54
Citigroup
New York
$43K +$17.9K +490 +73%
Barclays
55
Barclays
United Kingdom
$1K -$15.2K -418 -96%
PRCM
56
Pine River Capital Management
Minnesota
– -$1.87M -61,509 Closed
BOTOTLSJU
57
Board of Trustees of The Leland Stanford Junior University
California
– -$1.52M -50,000 Closed
Victory Capital Management
58
Victory Capital Management
Texas
– -$853K -28,090 Closed
HSBC Holdings
59
HSBC Holdings
United Kingdom
– -$643K -21,178 Closed
Norges Bank
60
Norges Bank
Norway
– -$607K -20,000 Closed
LCM
61
Laurion Capital Management
New York
– -$591K -19,462 Closed
CS
62
Credit Suisse
Switzerland
– -$323K -10,640 Closed
SG Americas Securities
63
SG Americas Securities
New York
– -$114K -3,740 Closed
AIM
64
Acrospire Investment Management
Illinois
– -$15K -498 Closed
Royal Bank of Canada
65
Royal Bank of Canada
Ontario, Canada
– +$146 +4 New
1 2
3

ONC Hedge Fund Activity: Q1 2017 in Review

56 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q1 2017, worth a combined $645M — up 28% from $504M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new ONC positions and 9 closed out — a net gain of 4 holders — while 20 added to existing stakes and 11 trimmed.

The largest buyer was Myriad Asset Management, opening a new position worth an estimated $12M. The largest seller was Fosun International, cutting an estimated $3.81M.

  • 56 institutional investors held BeOne Medicines Ltd (ONC) as of Q1 2017, up from 54 in Q4 2016.
  • Funds reported $645M of BeOne Medicines Ltd stock for Q1 2017, up 28% quarter-over-quarter.
  • 13 funds opened new BeOne Medicines Ltd positions in Q1 2017 and 9 closed out, a net change of +4 holders.
  • The largest BeOne Medicines Ltd buyer in Q1 2017 was Myriad Asset Management, an estimated $12M added.
  • The largest BeOne Medicines Ltd seller in Q1 2017 was Fosun International, an estimated $3.81M sold.

Based on aggregated 13F filings for Q1 2017.